ClinicalTrials.gg
Drug

Tasimelteon clinical trials

Also written VEC-162, BMS-214778 and Hetlioz.

studies test it
26
open now
2
in phase 3
12
first study started
2004

How each study uses tasimelteon is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the tasimelteon studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Jan 2014 · HETLIOZ · NDA 205677 (FDA, Drugs@FDA)
European Union
3 Jul 2015 · Hetlioz · EMEA/H/C/003870 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

tasimelteon
20
Tasimelteon Oral Suspension
2

Brand

Hetlioz
2
Hetlioz™ 20 mg
1

Development codes

VEC-162
10
BMS-214778
4

Studies by the year they started

26 studies that test it; most in 2011 (6)

Studies that test tasimelteon, by start year
YearStudies
20041
20061
20071
20102
20116
20124
20141
20151
20162
20171
20181
20201
20221
20231
20241
20251

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
10
Phase 2
4
Phase 3
12
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 1

Vanda Pharmaceuticals (25) · Brigham and Women's Hospital (1)

Often tested with

Tested in the same studies.

Ethanol (1) · Fluvoxamine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test tasimelteon, phase 3 first.

Studies

Open first, then newest update. How each study uses tasimelteon is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 26

See all 26 studies that test tasimelteon →

Codes

What other systems call tasimelteon · ClinicalTrials.gg INT004575

  • MeSH (NLM) C478745tasimelteonOne source NLM
  • UNII (FDA) SHS4PU80D9TASIMELTEONConfirmed FDA, NLM, Wikidata
  • RxNorm 1490468Confirmed FDA, Wikidata
  • Wikidata Q7687250tasimelteonConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152515TasimelteonOne source FDA
  • DrugBank DB09071One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.